Breaking News
Get 40% Off 0
🎁 Free Gift Friday: Copy Legendary Investors' Portfolios in One Click Copy for Free
Close

Axsome Therapeutics Inc (AXSM)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Axsome Therapeutics Inc's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
73.68 -2.00    -2.64%
09/05 - Closed. Currency in USD ( Disclaimer )
Pre Market
75.00
+1.32
+1.79%
13:00:01 - Real-time Data
  • Volume: 895,339
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 73.65 - 76.56
Type:  Equity
Market:  United States
Axsome Therapeutics Inc 73.68 -2.00 -2.64%

AXSM Income Statement & Profits

 
Assess the Axsome Therapeutics Inc income statement, view the company's financial performance across their assets and liabilities. Select to view either quarterly or annual data.
AnnualQuarterly
Advanced Income Statement
Period Ending: 2024
31/03
2023
31/12
2023
30/09
2023
30/06
Total Revenue 75 71.53 57.79 46.7
Revenue 75 71.53 57.79 46.7
Other Revenue, Total - - - -
Cost of Revenue, Total 6.3 7.38 6.53 4.6
Gross Profit 68.7 64.15 51.26 42.1
Total Operating Expenses 143.69 127.1 120.09 105.7
Selling/General/Admin. Expenses, Total 98.97 87.31 83.19 78.94
Research & Development 36.83 30.8 28.77 20.58
Depreciation / Amortization 0.132 0.133 0.136 0.1
Interest Expense (Income) - Net Operating -1.08 -0.702 -0.757 -2.73
Unusual Expense (Income) - - - -
Other Operating Expenses, Total 2.54 2.18 2.23 4.22
Operating Income -68.69 -55.57 -62.3 -59
Interest Income (Expense), Net Non-Operating - - - -
Gain (Loss) on Sale of Assets - - - -
Other, Net -0.33 43.41 0.577 8.78
Net Income Before Taxes -68.36 -98.98 -62.88 -67.79
Provision for Income Taxes - -0.325 -0.678 -0.617
Net Income After Taxes -68.36 -98.65 -62.2 -67.17
Minority Interest - - - -
Equity In Affiliates - - - -
U.S GAAP Adjustment - - - -
Net Income Before Extraordinary Items -68.36 -98.65 -62.2 -67.17
Total Extraordinary Items - - - -
Net Income -68.36 -98.65 -62.2 -67.17
Total Adjustments to Net Income - - - -
Income Available to Common Excluding Extraordinary Items -68.36 -98.65 -62.2 -67.17
Dilution Adjustment - 0.153 - 0.082
Diluted Net Income -68.36 -98.8 -62.2 -67.25
Diluted Weighted Average Shares 47.39 47.33 47.12 43.67
Diluted EPS Excluding Extraordinary Items -1.44 -2.09 -1.32 -1.54
DPS - Common Stock Primary Issue - - - -
Diluted Normalized EPS -0.92 -0.743 -0.836 -0.884
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the income statement, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

AXSM Price Commentary

Write your thoughts about Axsome Therapeutics Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
taral patel
taral patel Aug 22, 2021 19:12
Saved. See Saved Items.
This comment has already been saved in your Saved Items
what is FDA approval results 🤔😳??
Steven Longworth
Steven Longworth Oct 21, 2020 11:43
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Approaching a good level to start buying
Rustam Garaev
Rustam Garaev Jan 10, 2020 4:50
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Don’t hesitate and buy this even at 90$ It is epic
Manuel Morgan
Manuel Morgan Dec 18, 2019 14:27
Saved. See Saved Items.
This comment has already been saved in your Saved Items
looks good to me. Good news in medical research
Jinu Pappachan
Jinu Pappachan Dec 18, 2019 14:27
Saved. See Saved Items.
This comment has already been saved in your Saved Items
what is that sir??
Manuel Morgan
Manuel Morgan Dec 18, 2019 14:27
Saved. See Saved Items.
This comment has already been saved in your Saved Items
have a looks the news about the company. They are working in new treatments, that's the reason of this huge jump of the price
Jinu Pappachan
Jinu Pappachan Dec 18, 2019 14:05
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Hi any body buying this???
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email